SynAct Pharma AB (STO:SYNACT)
17.78
-0.04 (-0.22%)
Sep 4, 2025, 3:58 PM CET
SynAct Pharma AB Market Cap
SynAct Pharma AB has a market cap or net worth of 956.74 million as of September 4, 2025. Its market cap has increased by 163.27% in one year.
Market Cap
956.74M
Enterprise Value
889.40M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
17.78
Market Cap Chart
Since July 11, 2016, SynAct Pharma AB's market cap has increased from 63.75M to 956.74M, an increase of 1,400.73%. That is a compound annual growth rate of 34.43%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 3, 2025 | 948.21M | 127.52% |
Dec 30, 2024 | 416.76M | 32.69% |
Dec 29, 2023 | 314.09M | -87.00% |
Dec 30, 2022 | 2.42B | -34.75% |
Dec 30, 2021 | 3.70B | 242.52% |
Dec 30, 2020 | 1.08B | 809.57% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Jul 11, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Swedish Orphan Biovitrum AB | 96.97B |
Sectra AB | 63.62B |
Getinge AB | 55.67B |
Camurus AB | 42.93B |
Medicover AB | 39.63B |
Asker Healthcare Group AB | 36.35B |
BioArctic AB | 28.06B |
AddLife AB | 21.33B |